Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.
Anna Koumarianou(University General Hospital Attikon), George Fountzilas(Hellenic Cooperative Oncology Group), George Pentheroudakis(Hellenic Cooperative Oncology Group), Ralph Wirtz, Vassiliki Kotoula(Aristotle University of Thessaloniki), I. Tzeveleki(AHEPA University Hospital), Christos Valavanis(Metaxa Hospital), Anastasia G Eleftheraki(Hellenic Cooperative Oncology Group), Elena Fountzilas(St. Luke's Hospital), Ioannis Xanthakis(Aristotle University of Thessaloniki), George Basdanis(Aristotle University of Thessaloniki), D. Mekras(AHEPA University Hospital), Konstantine T. Kalogeras(Aristotle University of Thessaloniki), Mattheos Bobos(Aristotle University of Thessaloniki)
PubMed
September 1, 2014
Cited by 26
Related Papers
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2014|760
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
|Annals of Oncology|2017|591
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
|Journal of Clinical Oncology|2010|488
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|393